Live Breaking News & Updates on Stoke Therapeutics|Page 6

Stay updated with breaking news from Stoke therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Stoke Therapeutics (NASDAQ:STOK) Shares Up 5.1%

Stoke Therapeutics (NASDAQ:STOK) Shares Up 5.1%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Jonathan Allan , Barry Ticho , Canaccord Genuity Group , Corton Capital Inc , Needham Company , Mirae Asset Global Investments Co , Capital Partners , Stoke Therapeutics Inc , Jpmorgan Chase Co , Stoke Therapeutics , Get Free Report , General Counsel Jonathan Allan , Asset Global Investments , Public Employees Retirement System , Stoke Therapeutics Daily ,

Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Eric Rojas , Augmentation Of Nuclear Gene Output , Stoke Therapeutics Inc , Annual Needham Virtual Healthcare Conference , Targeted Augmentation , Nuclear Gene Output , Investor Contact , Investor Relations , Stoke Therapeutics ,

Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Stoke Therapeutics, Inc. , a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that. ....

United States , United Kingdom , Stoke Therapeutics Inc , Augmentation Of Nuclear Gene Output , Stoke Therapeutics , Annual Needham Virtual Healthcare Conference , Targeted Augmentation , Nuclear Gene Output ,

Stoke Therapeutics (NASDAQ:STOK) Shares Gap Down to $13.50

Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report)’s stock price gapped down before the market opened on Monday . The stock had previously closed at $13.50, but opened at $13.22. Stoke Therapeutics shares last traded at $13.52, with a volume of 131,390 shares traded. Analyst Upgrades and Downgrades STOK has been the topic of a […] ....

Hong Kong , United States , Stephenj Tulipano , Securities Exchange Commission , Hong Kong Ltd , Jpmorgan Chase Co , Great West Life Assurance Co , Stoke Therapeutics Inc , Canaccord Genuity Group , Ensign Peak Advisors Inc , Stoke Therapeutics , Get Free Report , Genuity Group , Therapeutics Stock Down , Exchange Commission , Peak Advisors Inc , Kong Ltd , West Life Assurance , Quantbot Technologies , Stoke Therapeutics Daily ,